Noticias de XTLB_US

Noticias del mercado

Últimas noticias sobre XTLB_US — 64 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: XTLB_US ✕ 64 resultados
08/04/2026 XTLB_US — newser.com
What valuation model applies to XTL (XTLB) Stock | Price at $2.40, Down 1.84% - Debt Free Stocks
08/04/2026 XTLB_US — newser.com
What valuation model applies to XTL (XTLB) Stock | Price at $2.40, Down 1.84% - Crowd Entry Points
06/04/2026 XTLB_US — sonla.gov.vn
Is XTL (XTLB) Stock a Buy Now | Price at $2.36, Down 2.48% - High Attention Stocks
06/04/2026 XTLB_US — newser.com
Is XTL (XTLB) Stock a Buy Now | Price at $2.36, Down 2.48% - Top Trending Breakouts
01/04/2026 XTLB_US — Hargreaves Lansdown
XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB
23/03/2026 XTLB_US — Stock Titan
XTL Biopharmaceuticals (XTLB) director discloses options on 1,000,000 shares
23/03/2026 XTLB_US — Stock Titan
XTL Biopharmaceuticals (XTLB) CFO Niv Segal files initial Form 3
20/03/2026 XTLB_US — Stock Titan
XTL investors will see every 4 ADSs become 1 on March 25
20/03/2026 XTLB_US — Investing.com
XTL Biopharmaceuticals plans 1-for-4 reverse ADS split
20/03/2026 XTLB_US — Stock Titan
XTL Biopharmaceuticals (NASDAQ: XTLB) sets one-for-four reverse ADS ratio change
20/03/2026 XTLB_US — Yahoo Finance
XTL Biopharmaceuticals Announces ADS Ratio Change
18/03/2026 XTLB_US — GuruFocus
Niv Segal Net Worth (2026)
10/03/2026 XTLB_US — Stock Titan
Beyond Air drops NeuroNOS sale, rethinks neurological and cancer plans
10/03/2026 XTLB_US — TipRanks
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires
10/03/2026 XTLB_US — The Manila Times ES ← EN
Beyond Air® anuncia la rescisión del acuerdo para vender su filial NeuroNOS a XTL Biopharmaceuticals Ltd.
27/02/2026 XTLB_US — Yahoo Finance
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
27/02/2026 XTLB_US — Stock Titan
Nasdaq moves to delist XTL, saying it is a public shell
27/02/2026 XTLB_US — Investing.com
XTL Biopharmaceuticals faces Nasdaq delisting notice
27/02/2026 XTLB_US — Quiver Quantitative
XTL Biopharmaceuticals Limited Faces Nasdaq Delisting Following Insolvency of Subsidiary The Social Proxy
27/02/2026 XTLB_US — Investing.com
XTL Biopharmaceuticals stock falls on Nasdaq delisting notice

Página 3 de 4

keyboard_arrow_up